The global 22q11.2 deletion syndrome therapeutics market is experiencing a period of significant growth, driven by factors such as increasing awareness of the condition and the development of novel therapeutic strategies . Researchers are actively investigating a wide range of therapeutic possibilities , including gene therapy, drug-based therapies